StructureChemical NameCASMF
(5β,9β,10α)-Beyer-15-en-3-one 28958-15-8 C20H30O
(+)-15-Beyerene 3564-54-3 C20H32
(5β,9β,10α)-Beyer-15-ene-3α,19-diol
(5β,9β,10α)-Beyer-15-ene-3α,17-diol
(-)-15-Beyerene 2359-73-1 C20H32
(5β,9β,10α)-Beyer-15-ene-17,18-diol 5945-49-3 C20H32O2
BEYER BROWN
beyer-15-en-18-oic acid 120852-64-4 C20H30O2
Bex1 protein
BEZAFIBRATE , RITODRINE
BEZAFIBRATE IMP. A (EP): N-(4-CHLOROBENZOYL)TYRAMINE MM(CRM STANDARD)
BEZAFIBRATE IMP. D (EP): ETHYL 2-[4-[2-[(4-CHLOROBENZOYL)AMINO]ETHYL]PHENOXY]-2-METHYLPROPIONATE MM(CRM STANDARD)
BEZAFIBRATE IMP. E (EP): BUTYL 2-[4-[2-[(4-CHLOROBENZOYL)AMINO]ETHYL]PHENOXY]-2-METHYLPROPIONATE MM(CRM STANDARD)
BEZAFIBRATE IMP. C (EP): METHYL 2-[4-[2-[(4-CHLOROBENZOYL)AMINO]ETHYL]PHENOXY] MM(CRM STANDARD)
bezafibroyl-coenzyme A 109881-30-3 C40H54ClN8O19P3S
BEZAFIBRATE IMP. B (EP): 4-CHLOROBENZOIC ACID MM(CRM STANDARD)
BEZAFIBRATE 63927-29-7 C19H20ClNO4
Bezafibrate 41859-67-0 C19H20ClNO4
B-110 FN 10 UL P/S SYRINGE
B-110 FN 25 UL P/S SYRINGE
B-110 FN 5 UL P/S SYRINGE
B-110 FN 50 UL P/S SYRINGE
Bezaldehyde C7H6O
BEZANTHRONE C18H12O
BfpA protein
Bezapril
BFP blue shifted GFP (Y66H):blue shifted GFP (Y66H)
BfpB protein
bexxar 208921-02-2
B29 gene product 120300-00-7
BfpE protein
BFP/GFP FRET
B-(4-Formyl-2-thienyl)boronic acid 1186026-19-6 C5H5BO3S
BezindineYellowWb
bezitramide 15301-48-1 C31H32N4O2
Bezitramide hydrochloride 59708-44-0
BGFNE
Bezoar
Bezoar artificaial
B2F protein 151472-20-7
BF-9 protocol
BEZ235 (Tosylate) 1028385-32-1 C37H31N5O4S
bfpT protein
BfrA protein
BfrB protein
BfrC protein
B-FREE
BFRF1 protein
BH 584 84777-88-8
B7-H4
BGIA protease inhibitor 136956-36-0
BF-S BlueFlash
bfr-1 protein 138880-50-9
bfr-2 protein 138880-49-6
BFR Recovery Spiking Standard Solution
BG III toxin 156680-12-5
BFR Spiking Solution
Bg II toxin 156680-13-6
BGJB MEDIUM
BGJb Medium Fitton- Jackson Modification w/L-Glutamine (Powder)/without Phenol Red
BGJb Medium Modified w/o L-Glutamine, Phenol Red (Powder)
BGJb Medium Modified w/o L-Glutamine (Powder)
BGJb Medium Fitton- Jackson Modification w/L-Glutamine (Powder)
BGJ culture medium
BH-AC-AMP protocol
BHAC-DMPV protocol
BH-AC-DMP protocol
BHADIMER
BFT3 protein
BFT2 protein
BFUI
BfuI (BciVI)
BGLB AGAR
BHA-LYSINE-BOC DENDRIMER, GENERATION 1
BHA-LYSINE-BOC DENDRIMER, GENERATION 0
Bhangra
11bH-Benzo(a)quinolizine, 1,2,3,4,6,7-hexahydro-2-beta-amino-9,10-dime thoxy-alpha-methyl-, dihydrochloride 39630-42-7 C16H24N2O2.2ClH
9bH-Benz[e]indene-5,9b-diol, dodecahydro-3a-methyl-, (3aR,5S,5aS,9aS,9bR)-rel- (9CI) 491862-21-6 C14H24O2
BglF protein
BGLF2 protein
BGLF4 protein
BHA PS resin, 1% DVB (200-400 mesh)
BHA PS resin, 1% DVB (100-200 mesh
bharangin 72711-84-3 C20H24O4
4bH,9bH,14bH-5,10,15-trioxa-14c-azabenzo[a]naphtho[1,2,3-de]anthracene
BHC 608-73-1 C6H6Cl6
BGL I 80449-04-3
BFuroseMide IMp. B (EP)
BGL II LINKER, 5'-PHOSPHORYLATED C78H100N30O55P8
BGL II LINKER
BGL II LINKER, 5'-NON-PHOSPHORYLATED
BGL II 81295-12-7
6-b-Furylacryloylamidopenicillanic Acid, TEA Salt
B-(2-FURYL)ACRYLICACID C7H6O3
B-2-FURYLETHANOL 35942-95-1 C6H8O2
BglJ protein
BHC (alpha isomer) (13C6) Solution
BHC (alpha isomer) Solution
BHA(UNSPECIFIED)
BHC (beta isomer) Solution
549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709